CAS 847494-64-8

Formel: C31H42BN3O5

InChl: InChI=1S/C31H42BN3O5/c1-18(2)15-26(32-39-25-17-21-16-24(30(21,4)5)31(25,6)40-32)34-29(38)27(19(3)36)35-28(37)23-14-10-13-22(33-23)20-11-8-7-9-12-20/h7-14,18-19,21,24-27,36H,15-17H2,1-6H3,(H,34,38)(H,35,37)/t19-,21+,24+,25-,26+,27+,31+/m1/s1

InChI Key: MQRLCCDKPUEHCQ-ABRLXTPQSA-N

SMILES: B1(O[C@@H]2C[C@@H]3C[C@H]([C@@]2(O1)C)C3(C)C)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)C4=CC=CC(=N4)C5=CC=CC=C5

N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide

Kontrolliertes Produkt

CAS: 847494-64-8

Applications N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide is an intermediate in the synthesis of Delanzomib (D230710), an orally active proteasome inhibitor.
References Roemmele, R.C., et al.: Org. Proc. Res. Develop., 17, 422 (2013);

Formel: C₃₁H₄₂BN₃O₅

Farbe und Form: Neat

Molekulargewicht: 547.49

Ref: TR-H294230

N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide

CAS: 847494-64-8

Formel: C₃₁H₄₂BN₃O₅

Farbe und Form: Solid

Molekulargewicht: 547.4933

Ref: IN-DA00G4W0